Skip to content
Assyro AI
Purple Book reference family · 351(a) biologic

Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed (Daptacel)

Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed is an FDA-licensed reference biologic from Sanofi Vaccines Canada Ltd..

351(a) biologicBLA 103666 Sanofi Vaccines Canada Ltd.
Biosimilars
0
Interchangeables
0
Listed patents
0
Reference approved
2002

Reference product

Originator biologic
Ask AI
351(a)BLA 103666

Daptacel Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed

Sanofi Vaccines Canada Ltd.

View full reference-product record
Approved
Marketing
Rx
Center
CBER
Patents
None listed

Exclusivity & patent cliffs

Protection horizon
Ask AI
  1. Reference approval

    Approval date of the reference Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed product.

    24 yr 11 mo ago

Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed: frequently asked questions

Reference exclusivity, biosimilars, interchangeability, and patents for this molecule, from the FDA Purple Book.

Built from official FDA Purple Book records (monthly downloads, the Advanced Search interface, and the published Patent List), with reference-product, license-type, and exclusivity context for Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed.

Related FDA reference tools

Assyro Intelligence

Ask anything about Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed

Cited answers from FDA, EMA, Health Canada, PubMed and ClinicalTrials.gov, in seconds. Free, no sign-up.

  • PubMed
  • ClinicalTrials.gov
  • FDA
  • Health Canada
  • EMA
  • ICH

Evaluating for a team? Book a demo